img

Global OTC Anti-Infective Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Anti-Infective Drug Market Insights, Forecast to 2034

Anti-infectives are medicines that work to prevent or treat infections.
Market Analysis and InsightsGlobal OTC Anti-Infective Drug Market
Global OTC Anti-Infective Drug market is expected to reach to US$ 23530 million in 2024, with a positive growth of %, compared with US$ 22510 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, OTC Anti-Infective Drug industry is evaluated to reach US$ 37880 million in 2029. The CAGR will be 8.3% during 2024 to 2029.
The Over-the-Counter (OTC) Anti-Infective Drug market has grown as a convenient option for consumers seeking self-treatment for minor infections. These drugs, available without a prescription, include topical ointments, creams, and oral medications for conditions like skin infections, cold sores, and vaginal infections. The market's expansion is driven by the demand for accessible and cost-effective solutions to address common infections without the need for a doctor's visit. As awareness of self-care and health empowerment increases, the OTC Anti-Infective Drug market continues to offer a range of effective options that enable individuals to manage mild infections quickly and conveniently.
Report Covers
This report presents an overview of global OTC Anti-Infective Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global OTC Anti-Infective Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Other

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Anti-Infective Drug introduction, etc. OTC Anti-Infective Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of OTC Anti-Infective Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Other
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Drug Market Perspective (2018-2029)
2.2 Global OTC Anti-Infective Drug Growth Trends by Region
2.2.1 OTC Anti-Infective Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2018-2024)
2.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2024-2029)
2.3 OTC Anti-Infective Drug Market Dynamics
2.3.1 OTC Anti-Infective Drug Industry Trends
2.3.2 OTC Anti-Infective Drug Market Drivers
2.3.3 OTC Anti-Infective Drug Market Challenges
2.3.4 OTC Anti-Infective Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue OTC Anti-Infective Drug by Players
3.1.1 Global OTC Anti-Infective Drug Revenue by Players (2018-2024)
3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2018-2024)
3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Anti-Infective Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global OTC Anti-Infective Drug Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2022
3.5 Global Key Players of OTC Anti-Infective Drug Head office and Area Served
3.6 Global Key Players of OTC Anti-Infective Drug, Product and Application
3.7 Global Key Players of OTC Anti-Infective Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Drug Breakdown Data by Type
4.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2018-2024)
4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029)
5 OTC Anti-Infective Drug Breakdown Data by Application
5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2018-2024)
5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Anti-Infective Drug Market Size (2018-2029)
6.2 North America OTC Anti-Infective Drug Market Size by Type
6.2.1 North America OTC Anti-Infective Drug Market Size by Type (2018-2024)
6.2.2 North America OTC Anti-Infective Drug Market Size by Type (2024-2029)
6.2.3 North America OTC Anti-Infective Drug Market Share by Type (2018-2029)
6.3 North America OTC Anti-Infective Drug Market Size by Application
6.3.1 North America OTC Anti-Infective Drug Market Size by Application (2018-2024)
6.3.2 North America OTC Anti-Infective Drug Market Size by Application (2024-2029)
6.3.3 North America OTC Anti-Infective Drug Market Share by Application (2018-2029)
6.4 North America OTC Anti-Infective Drug Market Size by Country
6.4.1 North America OTC Anti-Infective Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America OTC Anti-Infective Drug Market Size by Country (2018-2024)
6.4.3 North America OTC Anti-Infective Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe OTC Anti-Infective Drug Market Size (2018-2029)
7.2 Europe OTC Anti-Infective Drug Market Size by Type
7.2.1 Europe OTC Anti-Infective Drug Market Size by Type (2018-2024)
7.2.2 Europe OTC Anti-Infective Drug Market Size by Type (2024-2029)
7.2.3 Europe OTC Anti-Infective Drug Market Share by Type (2018-2029)
7.3 Europe OTC Anti-Infective Drug Market Size by Application
7.3.1 Europe OTC Anti-Infective Drug Market Size by Application (2018-2024)
7.3.2 Europe OTC Anti-Infective Drug Market Size by Application (2024-2029)
7.3.3 Europe OTC Anti-Infective Drug Market Share by Application (2018-2029)
7.4 Europe OTC Anti-Infective Drug Market Size by Country
7.4.1 Europe OTC Anti-Infective Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe OTC Anti-Infective Drug Market Size by Country (2018-2024)
7.4.3 Europe OTC Anti-Infective Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China OTC Anti-Infective Drug Market Size (2018-2029)
8.2 China OTC Anti-Infective Drug Market Size by Type
8.2.1 China OTC Anti-Infective Drug Market Size by Type (2018-2024)
8.2.2 China OTC Anti-Infective Drug Market Size by Type (2024-2029)
8.2.3 China OTC Anti-Infective Drug Market Share by Type (2018-2029)
8.3 China OTC Anti-Infective Drug Market Size by Application
8.3.1 China OTC Anti-Infective Drug Market Size by Application (2018-2024)
8.3.2 China OTC Anti-Infective Drug Market Size by Application (2024-2029)
8.3.3 China OTC Anti-Infective Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia OTC Anti-Infective Drug Market Size (2018-2029)
9.2 Asia OTC Anti-Infective Drug Market Size by Type
9.2.1 Asia OTC Anti-Infective Drug Market Size by Type (2018-2024)
9.2.2 Asia OTC Anti-Infective Drug Market Size by Type (2024-2029)
9.2.3 Asia OTC Anti-Infective Drug Market Share by Type (2018-2029)
9.3 Asia OTC Anti-Infective Drug Market Size by Application
9.3.1 Asia OTC Anti-Infective Drug Market Size by Application (2018-2024)
9.3.2 Asia OTC Anti-Infective Drug Market Size by Application (2024-2029)
9.3.3 Asia OTC Anti-Infective Drug Market Share by Application (2018-2029)
9.4 Asia OTC Anti-Infective Drug Market Size by Region
9.4.1 Asia OTC Anti-Infective Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia OTC Anti-Infective Drug Market Size by Region (2018-2024)
9.4.3 Asia OTC Anti-Infective Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer OTC Anti-Infective Drug Introduction
11.1.4 Bayer Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK OTC Anti-Infective Drug Introduction
11.2.4 GSK Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.2.5 GSK Recent Developments
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva OTC Anti-Infective Drug Introduction
11.3.4 Teva Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.3.5 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Introduction
11.4.4 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Company Details
11.5.2 NOVARTIS Business Overview
11.5.3 NOVARTIS OTC Anti-Infective Drug Introduction
11.5.4 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.5.5 NOVARTIS Recent Developments
11.6 MYLAN
11.6.1 MYLAN Company Details
11.6.2 MYLAN Business Overview
11.6.3 MYLAN OTC Anti-Infective Drug Introduction
11.6.4 MYLAN Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.6.5 MYLAN Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma OTC Anti-Infective Drug Introduction
11.7.4 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.7.5 Sun Pharma Recent Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Company Details
11.8.2 CR SANJIU Business Overview
11.8.3 CR SANJIU OTC Anti-Infective Drug Introduction
11.8.4 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.8.5 CR SANJIU Recent Developments
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla OTC Anti-Infective Drug Introduction
11.9.4 Cipla Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.9.5 Cipla Recent Developments
11.10 Lingrui
11.10.1 Lingrui Company Details
11.10.2 Lingrui Business Overview
11.10.3 Lingrui OTC Anti-Infective Drug Introduction
11.10.4 Lingrui Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.10.5 Lingrui Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungal
Table 3. Key Players of Antibacterial
Table 4. Key Players of Antiviral
Table 5. Key Players of Antiseptics
Table 6. Key Players of Other
Table 7. Global OTC Anti-Infective Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global OTC Anti-Infective Drug Market Share by Region (2018-2024)
Table 11. Global OTC Anti-Infective Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global OTC Anti-Infective Drug Market Share by Region (2024-2029)
Table 13. OTC Anti-Infective Drug Market Trends
Table 14. OTC Anti-Infective Drug Market Drivers
Table 15. OTC Anti-Infective Drug Market Challenges
Table 16. OTC Anti-Infective Drug Market Restraints
Table 17. Global OTC Anti-Infective Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global OTC Anti-Infective Drug Revenue Share by Players (2018-2024)
Table 19. Global Top OTC Anti-Infective Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
Table 20. Global OTC Anti-Infective Drug Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by OTC Anti-Infective Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of OTC Anti-Infective Drug, Headquarters and Area Served
Table 23. Global Key Players of OTC Anti-Infective Drug, Product and Application
Table 24. Global Key Players of OTC Anti-Infective Drug, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global OTC Anti-Infective Drug Revenue Market Share by Type (2018-2024)
Table 28. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global OTC Anti-Infective Drug Revenue Market Share by Type (2024-2029)
Table 30. Global OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global OTC Anti-Infective Drug Revenue Share by Application (2018-2024)
Table 32. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global OTC Anti-Infective Drug Revenue Share by Application (2024-2029)
Table 34. North America OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America OTC Anti-Infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America OTC Anti-Infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America OTC Anti-Infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe OTC Anti-Infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe OTC Anti-Infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe OTC Anti-Infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. China OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 49. China OTC Anti-Infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 50. China OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 51. China OTC Anti-Infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia OTC Anti-Infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia OTC Anti-Infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia OTC Anti-Infective Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia OTC Anti-Infective Drug Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America OTC Anti-Infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer OTC Anti-Infective Drug Product
Table 69. Bayer Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 70. Bayer Recent Developments
Table 71. GSK Company Details
Table 72. GSK Business Overview
Table 73. GSK OTC Anti-Infective Drug Product
Table 74. GSK Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 75. GSK Recent Developments
Table 76. Teva Company Details
Table 77. Teva Business Overview
Table 78. Teva OTC Anti-Infective Drug Product
Table 79. Teva Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 80. Teva Recent Developments
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson OTC Anti-Infective Drug Product
Table 84. Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 85. Johnson & Johnson Recent Developments
Table 86. NOVARTIS Company Details
Table 87. NOVARTIS Business Overview
Table 88. NOVARTIS OTC Anti-Infective Drug Product
Table 89. NOVARTIS Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 90. NOVARTIS Recent Developments
Table 91. MYLAN Company Details
Table 92. MYLAN Business Overview
Table 93. MYLAN OTC Anti-Infective Drug Product
Table 94. MYLAN Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 95. MYLAN Recent Developments
Table 96. Sun Pharma Company Details
Table 97. Sun Pharma Business Overview
Table 98. Sun Pharma OTC Anti-Infective Drug Product
Table 99. Sun Pharma Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 100. Sun Pharma Recent Developments
Table 101. CR SANJIU Company Details
Table 102. CR SANJIU Business Overview
Table 103. CR SANJIU OTC Anti-Infective Drug Product
Table 104. CR SANJIU Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 105. CR SANJIU Recent Developments
Table 106. Cipla Company Details
Table 107. Cipla Business Overview
Table 108. Cipla OTC Anti-Infective Drug Product
Table 109. Cipla Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 110. Cipla Recent Developments
Table 111. Lingrui Company Details
Table 112. Lingrui Business Overview
Table 113. Lingrui OTC Anti-Infective Drug Product
Table 114. Lingrui Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 115. Lingrui Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global OTC Anti-Infective Drug Market Share by Type: 2022 VS 2029
Figure 3. Antifungal Features
Figure 4. Antibacterial Features
Figure 5. Antiviral Features
Figure 6. Antiseptics Features
Figure 7. Other Features
Figure 8. Global OTC Anti-Infective Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global OTC Anti-Infective Drug Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. OTC Anti-Infective Drug Report Years Considered
Figure 14. Global OTC Anti-Infective Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global OTC Anti-Infective Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global OTC Anti-Infective Drug Market Share by Region: 2022 VS 2029
Figure 17. Global OTC Anti-Infective Drug Market Share by Players in 2022
Figure 18. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by OTC Anti-Infective Drug Revenue in 2022
Figure 20. North America OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America OTC Anti-Infective Drug Market Share by Type (2018-2029)
Figure 22. North America OTC Anti-Infective Drug Market Share by Application (2018-2029)
Figure 23. North America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 24. United States OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe OTC Anti-Infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe OTC Anti-Infective Drug Market Share by Type (2018-2029)
Figure 28. Europe OTC Anti-Infective Drug Market Share by Application (2018-2029)
Figure 29. Europe OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 30. Germany OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China OTC Anti-Infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China OTC Anti-Infective Drug Market Share by Type (2018-2029)
Figure 38. China OTC Anti-Infective Drug Market Share by Application (2018-2029)
Figure 39. Asia OTC Anti-Infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia OTC Anti-Infective Drug Market Share by Type (2018-2029)
Figure 41. Asia OTC Anti-Infective Drug Market Share by Application (2018-2029)
Figure 42. Asia OTC Anti-Infective Drug Market Share by Region (2018-2029)
Figure 43. Japan OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 53. Brazil OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 60. GSK Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 61. Teva Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 62. Johnson & Johnson Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 63. NOVARTIS Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 64. MYLAN Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 65. Sun Pharma Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 66. CR SANJIU Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 67. Cipla Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 68. Lingrui Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries